Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview

Immunocompromised (IC) persons are at increased risk for herpes zoster (HZ) and its complications, mainly due to impairment of cell-mediated immunity (CMI). The adjuvanted recombinant zoster vaccine (RZV) demonstrated efficacy against HZ in autologous hematopoietic stem cell transplant (auto-HSCT) r...

Descripció completa

Dades bibliogràfiques

Autors principals:	Alemnew F. Dagnew, Peter Vink, Mamadou Drame, David O. Willer, Bruno Salaun, Anne E. Schuind
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2021-11-01
Col·lecció:	Human Vaccines & Immunotherapeutics
Matèries:	humoral immunity cell-mediated immunity immune response adjuvanted recombinant zoster vaccine immunocompromised
Accés en línia:	http://dx.doi.org/10.1080/21645515.2021.1930846
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!